Tianjin Medical University General Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.tjmugh.com.cn

Clinical Trials

Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders

Phase 1

Withdrawn

Conditions: Neuromyelitis Optica Spectrum Disorder Relapse

Interventions: Drug: Ruxolitinib

First Posted Date: 2023-06-18

Last Posted Date: 2023-06-18

Lead Sponsor: Tianjin Medical University General Hospital

Registration Number: NCT05909943

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 2

Not yet recruiting

Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Toripalimab
Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2023-05-17

Last Posted Date: 2023-05-17

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 23

Registration Number: NCT05861557

Locations: 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
🇨🇳
Tianjin Medical University General Hospital, Tianjin, China

Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders

Phase 1

Recruiting

Conditions: NMO Spectrum Disorder

Interventions: Drug: Baricitinib

First Posted Date: 2023-03-31

Last Posted Date: 2024-10-16

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 12

Registration Number: NCT05792462

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Recruiting

Conditions: Neuromyelitis Optica Spectrum Disorder
Demyelinating Diseases of the Central Nervous System
Multiple Sclerosis

Interventions: Drug: Ofatumumab

First Posted Date: 2022-06-10

Last Posted Date: 2022-10-20

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 34

Registration Number: NCT05414487

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

Phase 2

Recruiting

Conditions: Neuromyelitis Optica Spectrum Disorder
NMO Spectrum Disorder
Neuromyelitis Optica

Interventions: Drug: Placebo
Drug: Daratumumab

First Posted Date: 2022-06-03

Last Posted Date: 2024-12-03

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 135

Registration Number: NCT05403138

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Propranolol on Post Stroke Immune Status and Infection

Phase 2

Conditions: Ischemic Stroke
Propranolol
Physiological Effects of Drugs
Nervous System Diseases
Cerebrovascular Disorders
Brain Diseases
Stroke
Central Nervous System Diseases
Immunologic Factors
Cardiovascular Diseases

Interventions: Drug: Propranolol
Drug: Ceftriaxone

First Posted Date: 2022-05-16

Last Posted Date: 2022-05-16

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 45

Registration Number: NCT05375240

Locations: 🇨🇳
Beijing Tiantan Hospital, Beijing, China
🇨🇳
Tianjin Medical University General Hospital, Tianjin, China

Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage

Phase 2

Recruiting

Conditions: Intracerebral Haemorrhage

Interventions: Drug: Standard treatment+mirabegron
Other: Standard treatment

First Posted Date: 2022-05-11

Last Posted Date: 2024-02-13

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 25

Registration Number: NCT05369351

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery

Not Applicable

Conditions: Postoperative Pain
Postoperative Nausea and Vomiting

Interventions: Drug: Normal saline
Drug: Ropivacaine at high concentration
Drug: Ropivacaine and dexamethasone

First Posted Date: 2022-03-18

Last Posted Date: 2022-03-18

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 90

Registration Number: NCT05286008

The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia Gravis

Completed

Conditions: Detection Autoantibody of Myasthenia Gravis

Interventions: Diagnostic Test: CBA Assay

First Posted Date: 2022-02-01

Last Posted Date: 2023-01-19

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 2663

Registration Number: NCT05219097

Locations: 🇨🇳
Beijing Tiantan Hospital, Beijing, China
🇨🇳
Tianjin Medical University General Hospital, Tianjin, China

Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

Phase 1

Completed

Conditions: NMO Spectrum Disorder

Interventions: Drug: Belimumab

First Posted Date: 2021-12-13

Last Posted Date: 2024-10-16

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 14

Registration Number: NCT05154734

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy